Close

Sanofi (SNY) Announces Positive Data from Post-Hoc Analysis of iGlarLixi Phase III in T2D

Go back to Sanofi (SNY) Announces Positive Data from Post-Hoc Analysis of iGlarLixi Phase III in T2D